Annamaria Ruzzo

University of Urbino — Italy

Medicine · Health Sciences

32h-index4.6kcitations117works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(49), Gastric Cancer Management and Outcomes(16), Genetic factors in colorectal cancer(16), Lung Cancer Treatments and Mutations(14), Cancer Treatment and Pharmacology(13)

Publications117 total

1898P Multicenter prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms (SNPs) in patients with metastatic lung adenocarcinoma (MLA) treated with pembrolizumab (P)
Annals of Oncology·2025
Clinical impact of <i>TP53</i> functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy
The Oncologist·2024· 1 citedOpen Access
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
Scientific Reports·2023· 2 citedOpen Access
2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1
Annals of Oncology·2023Open Access
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
Frontiers in Oncology·2021· 7 citedOpen Access
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
Frontiers in Oncology·2021· 19 citedOpen Access
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
Cancers·2020· 24 citedOpen Access
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with anti-angiogenic or standard chemotherapy regimens.
Journal of Clinical Oncology·2020
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
Gastric Cancer·2020· 12 citedOpen Access
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
Scientific Reports·2020· 1 citedOpen Access
MetaTropismDB: a database of organ-specific metastasis induced by human cancer cell lines in mouse models
Database·2020· 5 citedOpen Access
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
Scientific Reports·2019· 19 citedOpen Access
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
Bone Marrow Transplantation·2019· 1 cited
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
Frontiers in Oncology·2018· 56 citedOpen Access
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
Nature Medicine·2018· 8 citedOpen Access
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
Nature Medicine·2018· 268 citedOpen Access
Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial
Annals of Oncology·2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
British Journal of Cancer·2017· 68 citedOpen Access
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma
Cancer·2016· 44 citedOpen Access
Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
Scientific Reports·2016· 24 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Mauro Magnani(41), Francesco Graziano(40), Daniele Santini(28), Giuseppe Tonini(27), Fotios Loupakis(21), Emanuele Canestrari(21), Vincenzo Catalano(21), Alfredo Falcone(19), Bruno Vincenzi(18), Eliana Rulli(11), Paolo Enrico Maltese(10), Renato Bisonni(10), Chiara Cremolini(9), Gianluca Masi(9), Stefano Cascinu(9), Lucio Giustini(9), Lisa Salvatore(8), Irene Floriani(8), Nadia Galluccio(8), Francesca Pizzagalli(8)